Major Shareholders

Summary of Issued Securities 

Ordinary Shares

 
Issued shares at 31 March 2022

548,923,163

Employee options over ordinary shares at 31 March 2022

25,047,850

Major Shareholders 
The top 20 shareholders in Pharmaxis Ltd at 31 March 2022 are:

Name

Number Of Shares

'000

% Total 
1. Citicorp Nominees Pty Limited 129,567 24%
2. HSBC Custody Nominees (Australia) Limited - A/C 2 71,314 13%
3. HSBC Custody Nominees (Australia) Limited 12,360 2%
4. Lawn Views Pty Ltd (Angela Williams Family A/C) 10,351 2%
5. D&A Income Limited 9,524 2%
6. Dr Toby David Cohen 6,749 1%
7. BNP Paribas Nominees Pty Ltd Six SIS Ltd (DRP a/c) 5,275 1%
8. Healthcare Management Consulting (Australia) Pty Ltd 3,858 1%
9. Indcorp Consulting Group Pty Limited (Superannuation Fund A/C) 3,000 1%
10. Mr Alvin Liau 2,950 1%
11. BNP Paribas Nominees Pty Ltd ACF Clearstream 2,933 1%
12. Pakasoluto Pty Limited (Barkl Family Super Fund) 2,622 0%
13. Bunyula Super Pty Ltd (Bunyula Family Super Fund A/C) 2,477 0%
14. Mr David Curzon Smith + Mrs Diane Maurine Smith (Badham Family a/c) 2,306 0%
15. Joseph Wallace Carson 2,286 0%
16. Mr Xing Jiang Xue 2,244 0%
17. Ms Bei Xu + Mr Donging Wu 2,223 0%
18. Mr Peter John Carr 2,140 0%
19. Mr Yingkai Li 2,100 0%
20. BNP Paribas Noms Pty Ltd (Global Markets DRP) 2,018 0%

Note: the above tables are updated after each quarter end

Substantial Shareholders 

Name Percent Date 
BVF Partners LP 19% 6 November 2020
Karst Peak Capital Limited 12% 11 February 2022
D&A Income Limited 7% 28 February 2019

Directors' Interests

Current director's interest notices can be found here: